|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MSDS   | : | 19-Norpregn-4-ene-3,20-dione,
17-(acetyloxy)-11-methyl-, (11-beta)-
| | CAS   | : | 25092-41-5 | | SYNONYMS   | : | * 17-(Acetyloxy)-11-beta-methyl-19-norpregn-4-ene-3,20-dione
* 17-alpha-Acetoxy-11-beta-19-norpreg-4-ene-3,20-dione
* Norgestomet
* 19-Norpregn-4-ene-3,20-dione, 17-hydroxy-11-beta-methyl-, acetate
* Norprogesterone
* SC 21009
|
| |
|
|
|
|
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : RC8960540
CHEMICAL NAME : 19-Norpregn-4-ene-3,20-dione,
17-(acetyloxy)-11-methyl-, (11-beta)-
CAS REGISTRY NUMBER : 25092-41-5
LAST UPDATED : 199303
DATA ITEMS CITED : 1
MOLECULAR FORMULA : C23-H32-O4
MOLECULAR WEIGHT : 372.55
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
SYNONYMS/TRADE NAMES :
* 17-(Acetyloxy)-11-beta-methyl-19-norpregn-4-ene-3,20-dione
* 17-alpha-Acetoxy-11-beta-19-norpreg-4-ene-3,20-dione
* Norgestomet
* 19-Norpregn-4-ene-3,20-dione, 17-hydroxy-11-beta-methyl-, acetate
* Norprogesterone
* SC 21009
*** HEALTH HAZARD DATA ***
** REPRODUCTIVE DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Implant
SPECIES OBSERVED : Mammal - cattle
DOSE : 177 mg/kg
SEX/DURATION : female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
Endocrine - effect on menstrual cycle
REFERENCE :
THGNBO Theriogenology. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022)
V.1- 1974- Volume(issue)/page/year: 37,619,1992
*** END OF RECORD ***
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| | NAME | CAS |
|
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol,(17-alpha)-, mixt. with (17-alpha)-19-norpregn-4-en-20-yn-17-ol
| 8064-76-4 |
|
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-(cyclopentyloxy)-
| 152-43-2 |
|
19-Norpregna-1,3,5(10)-trien-20-yn-17-ol,3-(cyclopentyloxy)-11-methyl-, (11-beta,17-alpha)-
| 55648-36-7 |
|
Nicotine, 1,1'-dioxide, dihydrochloride, dihydrate
| 55648-36-7 |
|
17-alpha-19-Norpregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-
| 72-33-3 |
|
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 6-chloro-17-hydroxypregna-4,6-diene-3,20-dione
| 72-33-3 |
|
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 21-fluoro-17-hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
| 72-33-3 |
|
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 17-hydroxy-6-methyl-pregna-4,6-dien-3-one acetate
| 72-33-3 |
|
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 17-hydroxy-19-nor-17-alpha-pregna-4,20-dien-3-one
| 72-33-3 |
|
19-Nor-17-alpha-pregna-4,9,11-trien-20-yn-3-one,17-hydroxy-
| 848-21-5 |
|
19-Norpregna-4,9,11-trien-20-yn-3-one, 17-hydroxy-,oxime, (17-alpha)-
| 19636-23-8 |
|
19-Nor-17-alpha-pregna-4,9,11-trien-20-yn-3-one,17-hydroxy-, and testosterone
| 19636-23-8 |
|
19-Nor-17-alpha-pregn-4-ene-3,17-beta-diol, 3-acetate
| 101832-66-0 |
|
A-Nor-17-alpha-pregn-20-ene-2-beta,17-diol,2-ethynyl-20,21,21-trifluoro-
| 101832-66-0 |
|
Nicotine dustSUBSTANCE DEFINITION :Contains 4% nicotine.REFERENCE :JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-Volume(issue)/page/year: 93,407,1948
| 101832-66-0 |
|
19-Nor-17-alpha-pregn-4-ene-3,17-diol, 3-propionate
| 101832-66-0 |
|
A-Nor-17-alpha-pregn-20-ene-2-beta,17-beta-diol,2-alpha-ethynyl-20,21,21-trifluoro-
| 52-47-1 |
|
19-Norpregn-4-ene-3,20-dione
| 472-54-8 |
|
19-Norpregn-4-ene-3,20-dione,17-(acetyloxy)-11-methyl-, (11-beta)-
| 25092-41-5 |
|
19-Norpregn-4-ene-3,20-dione, 4-chloro-
| 99950-46-6 |
|
19-Norpregn-4-ene-3,20-dione,16-ethyl-21-((1-oxododecyl)oxy)-, (16-alpha)-
| 67490-00-0 |
|
19-Norpregn-4-ene-3,20-dione, 17-alpha-hydroxy-,acetate
| 67490-00-0 |
|
19-Norpregn-4-ene-3,20-dione, 17-hydroxy-, hexanoate
| 1253-28-7 |
|
19-Norpregn-4-ene-3,20-dione,17-hydroxy-16-methylene-, acetate
| 7759-35-5 |
|
19-Norpregn-9-ene-3,20-dione, 5-methyl-, (5-beta)-
| 130917-92-9 |
|
Nicotine, hydrochloride, (-)-
| 21361-93-3 |
|
19-Nor-17-alpha-pregn-4-en-17-ol
| 965-90-2 |
|
19-Nor-17-alpha-pregn-5-en-20-yn-17-ol
| 16915-71-2 |
|
19-Norpregn-17(20)-en-3-one
| 16915-71-2 |
|
19-Nor-17-alpha-pregn-4-en-3-one, 17,21-dihydroxy-
| 2436-31-9 |
|
19-Nor-17-alpha-pregn-4-en-3-one, 17-hydroxy-
| 52-78-8 |
|
19-Nor-17-alpha-pregn-5(10)-en-3-one, 17-hydroxy-
| 6318-07-6 |
|
19-Nor-17-alpha-pregn-4-en-3-one, 17-hydroxy-,acetate
| 18063-30-4 |
|
19-Nor-17-alpha-pregn-4-en-3-one, 17-hydroxy-, andtestosterone
| 18063-30-4 |
|
19-Nor-17-alpha-pregn-4-en-3-one, 17,20(or21),21-trihydroxy-
| 18063-30-4 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diol
| 1231-93-2 |
|
Nicotine, hydrochloride, (+)-
| 69782-38-3 |
|
19-Nor-17-alpha-pregn-5(10)-en-20-yne-3-alpha,17-diol
| 21466-08-0 |
|
19-Nor-17-alpha-pregn-5(10)-en-20-yne-3-beta,17-diol
| 2307-97-3 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diol,17-acetate
| 2061-46-3 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3,17-diol,diacetate
| 6785-71-3 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-dioldiacetate
| 297-76-7 |
|
19-Nor-17-alpha-pregn-5(10)-en-20-yne-3,17-beta-diol,diacetate
| 101858-17-7 |
|
19-Norpregn-4-en-20-yne-3-beta,17-diol, diacetate,mixt. with 3-methoxy-17-alpha-19-norpregna-1,3,5(10)-trien-20-yn-17-ol (5:1)
| 101858-17-7 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3,17-diol,diacetate, and 3-methoxy-19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol
| 101858-17-7 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-dioldiacetate mixed with 3-methoxy-19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol
| 101858-17-7 |
|
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diolmixed with 3-methoxy-17-alpha-19-norpregna-1,3,5(10)-trien-20-yn-17-ol
| 8056-92-6 |
|
Nicotine, hydrochloride
| 2820-51-1 |
|
19-Nor-17-alpha-pregn-4-en-20-yn-17-ol
| 52-76-6 |
|
19-Nor-17-alpha-pregn-5(10)-en-20-yn-17-ol,21-chloro-
| 52-76-6 |
|
|
|
|
|